In this episode, Dr. Hind Rafei dives into the cutting-edge world of CAR-NK cell therapy and its potential to revolutionize cancer treatment. Unlike their T-cell counterparts, CAR-NK cells promise enhanced safety and innate tumor-killing ability. But what if their power could be dialed up even further?
Dr. Rafei discusses her team's groundbreaking discovery ... Show More
Oct 24
From Beirut to Nobel Laureates: A Young Lebanese Scientist’s Inspiring Journey | Tala Kaddoura
From Lebanon’s economic crisis to the prestigious Lindau Nobel Laureate Meeting in Germany, AUB PhD researcher Tala Kaddoura shares her inspiring journey of perseverance, scientific discovery, and ambition. Discover how her groundbreaking research using 3D kidney organoids could ... Show More
25m 35s
Oct 18
Perimenopause Uncovered: The Symptoms Doctors Miss, Hormone Therapy Myths & What Every Woman Should Know | Dr. Nadine Hammoud
Brain fog, anxiety, sleepless nights, weight gain, and changes in sexual health—could perimenopause be the missing diagnosis? In this episode of The Lebanese Physicians Podcast, Dr. Nadine Hammoud, board-certified OB-GYN and Menopause Society Certified Practitioner, breaks down t ... Show More
50m 17s
Oct 13
Surviving the ICU Is Just the Beginning: The Hidden Struggles of Recovery | Dr. Hera Tashjian
What happens after a patient survives the ICU? Is survival enough, or should we be measuring something more? In this episode of The Lebanese Physicians Podcast, I speak with Dr. Hera Tashjian, Chief Nursing Officer at Almoosa Health Group in Saudi Arabia, about the often-overlook ... Show More
42m 22s
Sep 2020
Immunotherapy: Transforming How Cancers Are Treated
In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ... Show More
23m 44s
Nov 2024
CAR T Cells and T-Cell Therapies for Cancer
<p>CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott ... Show More
18m 22s
Aug 2024
CAR T-cell Therapy in AML: State of the Art
Tune in to our podcast for an in-depth discussion on immunotherapeutic strategies for Acute Myeloid Leukemia (AML). In this episode, we feature Dr Sarah Tettamanti, a senior scientist at the Fondazione Tettamanti Research Centre in Italy, who shares her expertise on CAR T-cell th ... Show More
15m 1s